A commentary on 'The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study'
Int J Surg
.
2023 Oct 1;109(10):3209-3210.
doi: 10.1097/JS9.0000000000000588.
Authors
Yuan Chen
1
,
Chengcheng Wang
,
Yupei Zhao
Affiliation
1
Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China.
PMID:
37402310
PMCID:
PMC10583943
DOI:
10.1097/JS9.0000000000000588
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Cross-Sectional Studies
Humans
Neoadjuvant Therapy*
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / surgery